North America Continuous Glucose Monitoring Device Market Size

North America Continuous Glucose Monitoring Device Market By Component (Sensors, Transmitters, and Receivers) By End User (Hospitals, Homecare Settings and Other End Users) By Country, Industry Analysis and Forecast, 2020 - 2026

North America Continuous Glucose Monitoring Device Market By Component (Sensors, Transmitters, and Receivers) By End User (Hospitals, Homecare Settings and Other End Users) By Country, Industry Analysis and Forecast, 2020 - 2026

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

Published Date : May-2020 | Number of Pages : 76 | Format : PDF

COVID-19

Get in-depth analysis of the COVID-19 impact on the North America Continuous Glucose Monitoring Device Market

The North America Continuous Glucose Monitoring Device Market would witness market growth of 11.6% CAGR during the forecast period (2020-2026). Continuous glucose monitors (CGMs) contain subcutaneous sensors that track interstitial glucose levels every 1-5 minutes, offering alerts when glucose levels are too high or too low, or increase or fall rapidly. CGMs transmit to a receiver which is either a pager-like device or an insulin pump integral to it. Looking at the continuous glucose graph and the alarm response can help patients avoid severe hyperglycemia or hypoglycemia.

These systems, unlike conventional glucose monitors, allow for periodic monitoring of glucose levels, which is critically important for avoiding diabetic complications. In fact, GCMS research has set out a blueprint for the artificial/bionic pancreas that is much awaited, high-tech, closed-loop. Thus, the development of novel and technologically advanced CGMS is the primary focus of the manufacturing companies that monitor glucose devices. It offers a broad range of applications for all age cohorts, healthcare settings, and geographies. Thus, the market for continuous glucose monitoring devices provides lucrative opportunities for producers of CGMS and manufacturers of insulin pumps.

Several governments across the globe are introducing various diabetes treatment measures, allowing continuous glucose monitoring devices to be more widely adopted. Diabetes challenges the US population's health in many ways. The high prevalence and cost of diabetes are two reasons that have enforced the US government to control diabetes more effectively. In order to better control diabetes, the government is implementing a variety of actions addressing lifestyle and socioeconomic factors, screening and medical management, and public awareness campaigns.

Based on Component, the market is segmented into Sensors, Transmitters, and Receivers. Based on End User, the market is segmented into Hospitals, Homecare Settings and Other End Users. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

Free Valuable Insights: Continuous Glucose Monitoring Device Market in North America is expected to register a CAGR of 11.6% during the forecast period (2020-2026)

The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, F. Hoffmann-La Roche Ltd., Novo Nordisk A/S, DexCom, Inc., Ypsomed AG, Senseonics Holdings, Inc., GlySens, Incorporated, A. Menarini Diagnostics Ltd. (The Menarini Group), Echo Therapeutics, Inc., Johnson and Johnson.

Scope of the North America Continuous Glucose Monitoring Device Market Analysis

Market Segmentation:

By Component

  • Sensors
  • Transmitters and
  • Receivers

By End User

  • Hospitals
  • Homecare Settings and
  • Other End Users

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Companies Profiled

  • Abbott Laboratories
  • Medtronic PLC
  • Hoffmann-La Roche Ltd.
  • Novo Nordisk A/S
  • DexCom, Inc.
  • Ypsomed AG
  • Senseonics Holdings, Inc.
  • GlySens, Incorporated
  • Menarini Diagnostics Ltd. (The Menarini Group)
  • Echo Therapeutics, Inc.
  • Johnson and Johnson

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Continuous Glucose Monitoring Device Market Related Reports:

Global Market

Europe Market

Asia Pacific Market

LAMEA Market


Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities